TMO:NYE-Thermo Fisher Scientific Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 393.66

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.32M

Analyst Target

USD 451.22
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-24 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

N/A

USD 140.35B
A Agilent Technologies Inc

N/A

USD 32.44B
IQV IQVIA Holdings Inc

N/A

USD 24.71B
LH Laboratory Corporation of Amer..

N/A

USD 20.88B
DGX Quest Diagnostics Incorporated

N/A

USD 19.12B
QGEN Qiagen NV

N/A

USD 9.05B
CRL Charles River Laboratories

N/A

USD 6.92B
ENZ Enzo Biochem Inc

N/A

USD 0.02B
MTD Mettler-Toledo International I..

N/A

N/A
WAT Waters Corporation

N/A

N/A

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 8.39 % 0.00 %

N/A

USD 4.89M
LIFE-U:CA Evolve Global Healthcare .. 5.51 % 0.00 %

N/A

N/A
DXSI:XETRA Xtrackers - Stoxx Europe .. 4.55 % 0.00 %

N/A

USD 0.02B
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.53 % 0.00 %

N/A

N/A
AILG 4.51 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

N/A

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.10 % 0.00 %

N/A

N/A
MHCD:CA Middlefield Healthcare Di.. 4.06 % 0.00 %

N/A

CAD 0.16B
XUHC:SW 4.03 % 0.00 %

N/A

N/A
IUHC:SW iShares S&P 500 Health Ca.. 3.92 % 0.00 %

N/A

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.92 % 0.00 %

N/A

N/A
WH2E:XETRA Invesco S&P World Health .. 3.83 % 0.00 %

N/A

N/A
LS:CA 3.73 % 2.21 %

N/A

N/A
XLV Health Care Select Sector.. 3.23 % 0.13 %

N/A

USD 33.98B
SXLV:SW SPDR S&P U.S. Health Care.. 3.21 % 0.00 %

N/A

N/A
ZPDH:F SPDR S&P U.S. Health Care.. 3.20 % 0.00 %

N/A

USD 0.40B
XUHC:F Xtrackers (IE) Public Lim.. 3.09 % 0.00 %

N/A

USD 0.85B
FHLC Fidelity® MSCI Health Ca.. 2.79 % 0.08 %

N/A

USD 2.37B
HEAW:LSE SPDR® MSCI World Health .. 2.71 % 0.00 %

N/A

N/A
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

N/A

N/A
CDNA:CA 2.59 % 0.00 %

N/A

N/A
CURE Direxion Daily Healthcare.. 2.53 % 1.06 %

N/A

USD 0.12B
FOHW:XETRA Franklin Future of Health.. 2.52 % 0.00 %

N/A

N/A
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.44 % 0.00 %

N/A

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.23 % 0.00 %

N/A

N/A
ABIT:F AXA IM ACT Biodiversity E.. 1.95 % 0.00 %

N/A

N/A
XMLH:F Legal & General Ucits Etf.. 1.91 % 0.00 %

N/A

N/A
HYLG 1.84 % 0.00 %

N/A

N/A
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

N/A

USD 30.70B
QUS:AU BetaShares S&P 500 Equal .. 0.23 % 0.00 %

N/A

USD 0.83B
IBLN 0.00 % 0.64 %

N/A

N/A
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

N/A

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

N/A

USD 0.91B
JMIN 0.00 % 0.12 %

N/A

N/A
ACT Enact Holdings Inc 0.00 % 0.75 %

N/A

USD 5.50B
KORP American Century Diversif.. 0.00 % 0.45 %

N/A

USD 0.49B
HWF:CA 0.00 % 0.00 %

N/A

N/A
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

N/A

CAD 0.02B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

N/A

N/A
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

N/A

N/A
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

N/A

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

N/A

N/A
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

N/A

CAD 0.56B
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

N/A

USD 2.40B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
WHEA:LSE SPDR® MSCI World Health .. 0.00 % 0.00 %

N/A

N/A
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

USD 0.65B
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

N/A

N/A
XDWH:XETRA Xtrackers MSCI World Heal.. 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

N/A

N/A
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

N/A

N/A
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
LONG:CA CI Global Longevity Econo.. 0.00 % 0.00 %

N/A

CAD 3.64M
XMLH:XETRA L&G Healthcare Breakthrou.. 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

N/A

USD 1.47B
DWEQ 0.00 % 0.00 %

N/A

N/A
DOCT:SW L&G Healthcare Breakthrou.. 0.00 % 0.00 %

N/A

USD 0.06B
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

N/A

N/A
CFCV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -24.33% 25% F 9% A-
Dividend Return 0.08% 17% F 1% F
Total Return -24.25% 25% F 8% B-
Trailing 12 Months  
Capital Gain -32.60% 33% F 9% A-
Dividend Return 0.27% 29% F 3% F
Total Return -32.32% 33% F 8% B-
Trailing 5 Years  
Capital Gain 15.69% 45% F 42% F
Dividend Return 1.85% 20% F 4% F
Total Return 17.54% 45% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 6.23% 58% F 60% D-
Dividend Return 6.43% 58% F 53% F
Total Return 0.20% 29% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 16.72% 83% B 58% F
Risk Adjusted Return 38.48% 100% F 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.